Allison C, Baron-Cohen S. Improving the recognition of autism in children and adults. Practitioner May 2018;262(1815):11-16
Improving the recognition of autism in children and adults
22 May 2018
AUTHORS
Dr Carrie Allison PhD, Director of Research Strategy
Professor Simon Baron-Cohen PhD FBA FMedSci, Director
Autism Research Centre, Cambridge University, Cambridge, UK
Competing interests: None
Article
Abstract
Autism is a set of neurodevelopmental conditions characterised by difficulties in social communication, alongside unusually narrow interests and strongly repetitive behaviour. Autism occurs in about 1% of people, which may be as many as 605,000 individuals in the UK. Autism covers a wide spectrum across the dimensions of social communication, repetitive and stereotyped behaviours as well as other non-clinical and cognitive features. Individuals with autism can function well in certain environments, where there are fewer demands to multitask and factual information and pattern recognition are required, but they may not function well in highly social environments, or situations characterised by rapid and unpredictable change. Autism has high heritability. Having an older sibling with autism increases the likelihood of autism in the next sibling by 20-32.2% and around 20% of parents of children with autism have a high number of autistic traits. NICE recommends that, when considering referral to the autism team, account should be taken of factors associated with increased prevalence of autism. GPs need to consider the family history and to take a detailed obstetric history when considering the possibility of autism. Autism symptoms generally manifest in early childhood yet many individuals experience delays in diagnosis and accessing specialist services. Screening tools may enable GPs to make informed decisions about whether the patient presenting to them is showing signs of autism which might warrant further investigation. Although a positive score may support a decision to refer a patient a negative score does not rule out autism. NICE recommends that patients should be referred if autism is suspected based on clinical judgement.
Autism is a set of neurodevelopmental conditions characterised by difficulties in social communication, alongside unusually narrow interests and strongly repetitive behaviour.1 Autism occurs in about 1% of people, which may be as many as 605,000 individuals in the UK. Autism has a male:female ratio of 3:1.
Autism covers a wide spectrum across the dimensions of social communication, repetitive and stereotyped behaviours as well as other non-clinical and cognitive features. Autistic people have a strong preference for predictability that can also manifest as a difficulty in adjusting to unexpected change. The autistic learning or cognitive style tends towards a preference for detail rather than seeing the bigger picture, a preference for factual and well specified precision rather than ambiguity, and a systematic, step by step logic rather than making big leaps. Sensory hypersensitivity is also very common, as are difficulties with executive function.
Individuals with autism can function well in certain environments, where there are fewer demands to multitask and factual information and pattern recognition are required. However, they may not function well in other kinds of environments, particularly highly social environments, or situations characterised by rapid and unpredictable change. In this sense it is all about the fit between the person and their environment, and the disability can be exacerbated or reduced depending on the environmental fit or environmental adjustments and modifications. Autism is best understood as a form of ‘neurodiversity’ i.e. where the brain is wired differently.
Individuals with autism may have one or more co-occurring conditions such as anxiety, depression, language delay, learning difficulties, gastrointestinal pain, self-injury, epilepsy, and attention deficit hyperactivity disorder (ADHD). These may be secondary to the autism (e.g. poor mental health may be the result of lack of support and/or negative life events such as bullying at school), while others may reflect co-occurring partly genetic conditions.
Identification of autism can be difficult because of its heterogeneity. The condition may be diagnosed in early childhood, or more commonly later in childhood or adolescence or even in adulthood (by which time the individual may have had a host of negative life experiences leading to worse mental health. High rates of suicidality in autistic people have been reported.2 This highlights the need for appropriate service planning and support to reduce risk in this group. NICE guidelines aim to improve recognition of autism in both childhood and adulthood.3,4
Causal factors
Autism has high heritability,5 with estimates of 40-50% of the variance in risk for autism being due to genetic factors. This has been established through twin studies, in monozygotic twins both individuals are more likely to be affected where one of the twins has autism than is the case with dizygotic twins. Having an older sibling with autism increases the likelihood of autism in the next sibling by 20-32.2%.6,7,8,9,10,11 Around 20% of parents of children with autism also show the broader autism phenotype, with a high number of autistic traits.12,13,14 The genetics of autism suggest it is polygenic and includes both rare genetic mutations and combinations of specific common genetic variants that we all carry.
Environmental and other factors that increase the likelihood of autism in the child include: advanced paternal or maternal reproductive age,15,16,17 polycystic ovary syndrome in the mother,18,19 pre-eclampsia,20 maternal infection during pregnancy,21 maternal gestational diabetes,22,23 high maternal BMI at age 18, low neonatal birthweight/gestational age, low neonatal Apgar score,24 maternal use of sodium valproate in pregnancy,25 and having an intellectual disability.26
NICE (CG 128) recommends that, when considering referral to the autism team, account should be taken of factors associated with increased prevalence of autism. GPs need to consider the family history and to take a detailed obstetric history when considering the possibility of autism.3
Symptoms
Autism symptoms generally manifest in early childhood yet many individuals experience delays in diagnosis and accessing specialist services. Signs and symptoms of autism in young children include: deficits or delays in the emergence of joint attention (e.g. looking at what a parent is looking at, or pointing at objects to share interest) and pretend play, taking an atypical perspective, reduced reciprocal affective behaviour, decreased response to hearing one’s own name, reduced imitation, delayed verbal and nonverbal communication, motor delay, unusually repetitive behaviours, atypical visuomotor exploration, inflexibility in disengaging visual attention, and extreme variation in temperament.
However, symptom presentations vary immensely. In older children, signs of autism may include ‘talking at’ others rather than a dialogue; long-standing difficulties in reciprocal social communication and interaction; reduced or absent understanding of friendship; social isolation and apparent preference for being alone; poorly integrated gestures, facial expressions, body orientation, and eye contact, highly repetitive behaviours or rituals that negatively affect daily activities; over- or under-reaction to sensory stimuli, for example textures, sounds, smells. They may have an unusual profile of skills and deficits (for example, social or motor coordination skills being poorly developed, while particular areas of knowledge, reading or vocabulary skills are advanced for chronological or mental age).
Older people presenting with possible autism may have previously camouflaged their autism or have been living in a supportive environment, making identification difficult especially in articulate individuals. Autistic girls and women may be missed or experience late diagnosis because of camouflaging their autism (perhaps because of greater social expectations on females to be sociable and communicative). Women may have been misdiagnosed with other mental health conditions, such as personality disorders or eating disorders,27,28 anxiety and depression.29,30
Screening tools
The GP’s role is vital in timely and accurate recognition of autistic traits in patients. GPs need to be able to identify patients who require a specialist diagnostic assessment and make appropriate referrals. However, in a survey 80% of GPs stated that they required guidance to identify people who may have autism.31 Parents may raise concerns about their child by 18 months but there is frequently a significant delay in arriving at a diagnosis. Delays in referring patients for a specialist diagnostic assessment can result in late diagnosis and delays in receiving appropriate intervention, help and support.
GPs may be the first point of contact for parents who may be concerned that their child has autism, as well as for adults who feel that they themselves may be autistic. Brief tools are useful for GPs to identify red flags to alert them to consider a referral for a diagnostic assessment.
The Autism Spectrum Quotient (AQ)32 was first developed to measure autistic traits in adults. The AQ has excellent sensitivity, specificity and positive predictive value (all > 0.80) in a clinically referred sample.33 There are now also child and adolescent versions of the AQ,34,35 along with an early developmental version called the Quantitative Checklist for Autism in Toddlers (Q-CHAT).36
Short versions have been developed and tested in large samples identifying the ten items that best differentiated people with and without autism,37 independently validated by Booth and colleagues.38 The AQ-10 is recommended in the NICE guideline (CG142) on autism in adults.4 These tools have the potential to help GPs make decisions in real clinic time about whether to make a referral for an assessment. Although a positive score may support a decision to refer a patient a negative score does not rule out autism. However, NICE also recommends that patients should be referred if autism is suspected based on clinical judgement.
To date, they have not been widely implemented and there is a need for more research to evaluate their use prospectively in primary care since most of the research comes from population or clinical studies where patients have already been referred.
Box 1 contains the Q-CHAT-10, to use with toddlers, box 2 the AQ-Child-10 for children age 4 to 11 years old, box 3 the AQ-Adol-10 for adolescents aged 12-15 years, and Box 4 the AQ-Adult-10 for those aged 16 years and older. The first three are parent reported, and the last one is self reported.
NICE recommends that assessment should be considered if an adult shows one or more of: persistent difficulties in social interaction, persistent difficulties in social communication, and stereotypic (rigid and repetitive) behaviours, resistance to change or restricted interests and at least one of the following: problems in obtaining or sustaining employment or education, difficulties in initiating or sustaining social relationships, previous or current contact with mental health or learning disability services, a history of a neurodevelopmental condition (including learning disabilities and ADHD) or a psychiatric condition.
The potential health benefits of screening for patients include faster referral to specialist diagnostic services, which may help to alleviate uncertainty, as well as secondary symptoms such as depression and anxiety.39,40 Patients with undiagnosed autism often find medical examinations and procedures make them anxious, which may be challenging for the clinician,41 and frustrating for the patients.
Confirming diagnosis
Diagnostic assessment should be multidisciplinary. NICE recommends that detailed questions about the caregiver’s concerns and, if appropriate, the patient’s concerns, be taken into consideration. A developmental history should be taken, using an autism-specific tool to gather information on developmental and behavioural features consistent with the diagnostic criteria. There should be: an assessment (through interaction with, and observation of, the child or young person) of social and communication skills and behaviours; a medical history;a physical examination; consideration of any differential diagnosis; systematic assessment for conditions that may coexist with autism; development of a profile of the child's or young person's strengths, skills, impairments and needs that can be used to create a needs-based management plan. The family and educational context also need to be taken into account.
NICE recommends that information from all sources, together with clinical judgment, should be used to diagnose autism based on ICD-10 or DSM-5 criteria. NICE also states that clinicians should not rely on any autism-specific diagnostic tool alone to diagnose autism. A revised edition (ICD-11) is expected in 2019 and will closely align with the latest edition of the American Diagnostic and Statistical Manual (DSM-5).
Assessment of adults can be challenging since the diagnosis relies on an informant to provide information about the person’s early development. This can be particularly problematic when parents have died and there is nobody else to provide this early developmental history.
Management approaches
Early intensive behavioural intervention (EIBI) is the most studied treatment model for autistic children. This is a variation of the applied behaviour analysis (ABA) approach and focuses on the premise that early intervention will be successful if: it occurs early (toddler/pre-school age), is intensive (> 20 hours/week), and long-term (> 2 years). EIBI includes the use of discrete trial training, is delivered one to one by an adult therapist, has individualised goal setting guided by typical developmental sequences and involves parents as co-therapists. The most recent Cochrane review42 found there to be weak evidence that EIBI may be an effective behavioural treatment for some autistic children. The studies were small and not of the optimum randomised design.
Alternatives to this approach include the Early Start Denver Model (ESDM) and Joint Attention Symbolic Play Engagement and Regulation (JASPER). A recent systematic review of 48 randomised controlled trials (RCTs)43 found positive significant outcomes in many trials (even at long-term follow-up beyond two years).44,45 However, these studies show small effect sizes, wide confidence intervals and there remain major methodological challenges for future trials.
A parent-mediated approach is another alternative in which parents are trained by professionals to deliver support to their children. However, a Cochrane review46 of 17 RCTs found no significant evidence of gain in children’s language and communication, initiation in parent-child interaction, adaptive behaviour, or parents’ stress. However, there were positive changes in parent-child interaction pattern on shared attention and parent synchrony as well as evident reduction of children’s autism characteristics.
There is now a body of evidence that indicates targeted intervention,47,48 designed to address a relatively narrow but pivotal goal or set of skills, in contrast to the comprehensiveness of EIBI, can be helpful to autistic children.49 For example, interventions that focus on enhancing social skills and peer relationships report potential positive outcomes in improving overall social competence and quality of friendships and reducing loneliness, with a recent meta-analysis indicating overall improvement in social functioning.50 Other kinds of interventions include supported employment schemes, supported living schemes, autism self-advocacy or support from an autism advocate, mentoring, and peer support groups. In the UK, the National Autistic Society website (see External websites) is a useful resource for identifying local agencies and services.
Conclusions
The increasing prevalence of autism over time, (previously rare and now very common, due to better awareness and changes in diagnostic criteria), is putting pressure on specialist diagnostic services to offer assessment and post-diagnostic support, which in many areas remains insufficient. GPs are often the gatekeepers to the referral for a diagnostic assessment, but there is a need for more and better training especially about the more subtle manifestations of autism.
Providing GPs with screening tools may enable them to make informed decisions about whether the patient presenting to them is showing signs of autism which might warrant further investigation. Identification is the first step towards autistic people accessing the support they need to lead fulfilling and rewarding lives.
REFERENCES
1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. American Psychiatric Publishing. Arlington, VA. 2013
2 Cassidy S, Bradley P, Robinson J et al. Suicidal ideation and suicide plans or attempts in adults with Asperger's syndrome attending a specialist diagnostic clinic: a clinical cohort study. Lancet Psychiatry 2014;1(2):142-47
3 National Institute for Health and Clinical Excellence. CG128. Autism spectrum disorder in under 19s: recognition, referral and diagnosis. NICE. London. 2011 www.nice.org.uk/guidance/cg128
4 National Institute for Health and Clinical Excellence. CG142. Autism spectrum disorder in adults: diagnosis and management. NICE. London. 2012 www.nice.org.uk/guidance/cg142
5 Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Part B, Neuropsychiatric genetics. Am J Med Gen 2011;156B(3):255-74
6 Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285(24): 3093-99
7 Icasiano F, Hewson P, Machet P et al. Childhood autism spectrum disorder in the Barwon region: a community based study. J Paediatr Child Health 2004;40(12):696-701
8 Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psychiatry 2005;46(9):963-71
9 Constantino JN, Zhang Y, Frazier T et al. Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 2010;167(11):1349-56
10 Xie F, Peltier M, Getahun D. Is the risk of autism in younger siblings of affected children moderated by sex, race/ethnicity, or gestational age? J Dev Behav Pediatr 2016;37(8):603-09
11 Ozonoff S, Young GS, Carter A et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 2011;128(3):e488-95
12 Wheelwright S, Auyeung B, Allison C, Baron-Cohen S. Defining the broader, medium and narrow autism phenotype among parents using the Autism Spectrum Quotient (AQ). Mol Autism 2010;1(1):10
13 Losh M, Childress D, Lam K, Piven J. Defining key features of the broad autism phenotype: A comparison across parents of multiple- and single-incidence autism families. Neuropsychiatric genetics: Am J Med Gen 2008;147B(4):424-33
14 Cruz LP, Camargos-Junior W, Rocha FL. The broad autism phenotype in parents of individuals with autism: a systematic review of the literature. Trends Psychiatry Psychother 2013;35(4):252-63
15 Sandin S, Hultman CM, Kolevzon A et al. Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2012;51(5):477-86 e1
16 Hultman CM, Sandin S, Levine SZ et al. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry 2011;16(12):1203-2
17 Lampi KM, Hinkka-Yli-Salomaki S, Lehti V et al. Parental age and risk of autism spectrum disorders in a Finnish national birth cohort. J Autism Dev Disord 2013;43(11): 2526-35
18 Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007;51(5):597-604
19 Pohl A, Cassidy S, Auyeung B, Baron-Cohen S. Uncovering steroidopathy in women with autism: a latent class analysis. Mol Autism 2014;5:27
20 Getahun D, Fassett MJ, Peltier MR et al. Association of perinatal risk factors with autism spectrum disorder. Am J Perinatol 2017;34(3):295-304
21 Brown AS, Sourander A, Hinkka-Yli-Salomaki S et al. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2014;19(2):259-64
22 Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009;195(1):7-14
23 Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011;128(2):344-55
24 Glasson EJ, Bower C, Petterson B et al. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004;61(6):618-27
25 Christensen J, Grønborg T, Sørensen M et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309(16):1696-703
26 Fombonne E, Quirke S, Hagen A. Epidemiology of pervasive developmental disorders. In: Amaral DG, Dawson G, Geschwind DH, editors. Autism Spectrum Disorders. Oxford University Press. New York, NY. 2011. pp 90-111
27 Lai MC, Baron-Cohen S. Identifying the lost generation of adults with autism spectrum conditions. Lancet Psychiatry 2015;2(11):1013-27
28 Mandy W, Tchanturia K. Do women with eating disorders who have social and flexibility difficulties really have autism? A case series. Mol Autism 2015;6:6
29 May ME, Brandt RC, Bohannan JK. Moderating effects of autism on parent views of genetic screening for aggression. Intellect Dev Disabil 2012;50(5):415-25
30 Oswald TM, Winter-Messiers MA, Gibson B et al. Sex differences in internalizing problems during adolescence in autism spectrum disorder. J Autism Dev Disord 2016;46(2):624-36
31 Medeconnect. Survey of General Practitioners in England on the subject of autism. Report (prepared for The National Audit Office). 2008
32 Baron-Cohen S, Wheelwright S, Skinner R et al. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord 2001;31(1):5-17
33 Woodbury-Smith MR, Robinson J, Wheelwright S, Baron-Cohen S. Screening adults for Asperger Syndrome using the AQ: a preliminary study of its diagnostic validity in clinical practice. J Autism Dev Disord 2005;35(3):331-35
34 Auyeung B, Baron-Cohen S, Wheelwright S, Allison C. The Autism Spectrum Quotient: Children's Version (AQ-Child). J Autism Dev Disord 2008;38(7):1230-40
35 Baron-Cohen S, Hoekstra RA, Knickmeyer R, Wheelwright S. The Autism-Spectrum Quotient (AQ)--adolescent version. J Autism Dev Disord 2006;36(3):343-50
36 Allison C, Baron-Cohen S, Wheelwright S et al. The Q-CHAT (Quantitative CHecklist for Autism in Toddlers): a normally distributed quantitative measure of autistic traits at 18-24 months of age: preliminary report. J Autism Dev Disord 2008;38(8):1414-25
37Allison C, Auyeung B, Baron-Cohen S. Toward brief "red flags" for autism screening: The Short Autism Spectrum Quotient and the Short Quantitative Checklist for Autism in toddlers in 1,000 cases and 3,000 controls [corrected]. J Am Acad Child Adolesc Psychiatry 2012;51(2):202-12 e7
38 Booth T, Murray AL, McKenzie K et al. Brief report: an evaluation of the AQ-10 as a brief screening instrument for ASD in adults. J Autism Dev Disord 2013;43(12):2997-3000
39 Ozsivadjian A, Hibberd C, Hollocks MJ. Brief report: The use of self-report measures in young people with autism spectrum disorder to access symptoms of anxiety, depression and negative thoughts. J Autism Dev Disord 2014;44(4):969-74
40 Simonoff E, Pickles A, Charman T et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008;47(8):921-29
41 Prayson B, Franco K. Is an adult with Asperger syndrome sitting in your waiting room? Cleve Clin J Med 2012;79(12):875-82
42 Reichow B, Hume K, Barton EE, Boyd BA. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2018;5:CD009260
43 French L, Kennedy EMM. Annual Research Review: Early intervention for infants and young children with, or at-risk of, autism spectrum disorder: a systematic review. J Child Psychology Psychiatry 2018;59(4):444-56
44 Estes A, Munson J, Rogers SJ et al. Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2015;54(7):580-87
45 Kasari C, Gulsrud A, Freeman S et al. Longitudinal follow-up of children with autism receiving targeted interventions on joint attention and play. J Am Acad Child Adolesc Psychiatry 2012;51(5):487-95
46 Oono IP, Honey EJ, McConachie H. Parent-mediated early intervention for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2013(4):CD009774
47 Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet 2014;383(9920):896-910
48 Wong C, Odom SL, Hume KA et al. Evidence-based practices for children, youth, and young adults with autism spectrum disorder: A comprehensive review. J Autism Dev Disord 2015;45(7):1951-66
49 Odom S, Hume K, Boyd B, Stabel A. Moving beyond the intensive behavior treatment versus eclectic dichotomy: evidence-based and individualized programs for learners with ASD. Behav Modif 2012;36(3):270-97
50 Gates JA, Kang E, Lerner MD. Efficacy of group social skills interventions for youth with autism spectrum disorder: A systematic review and meta-analysis. Clin Psychol Rev 2017;52:164-81
ARTICLE IN PDF
EXTERNAL WEBLINKS
NICE. CG 128. Autism spectrum disorder in under 19s: recognition, referral and diagnosis
NICE. CG142. Autism spectrum disorder in adults: diagnosis and management
Online versions of screening tools

